TH149018B - New form of drug packaging 1- (6 - [(3-cyclobutyl-2,3,4,5, -tetrahydro-1H-3-benzacipin-7-il) oxy] -3 - Pyridinil) -2- Piridinone And stabilizer - Google Patents

New form of drug packaging 1- (6 - [(3-cyclobutyl-2,3,4,5, -tetrahydro-1H-3-benzacipin-7-il) oxy] -3 - Pyridinil) -2- Piridinone And stabilizer

Info

Publication number
TH149018B
TH149018B TH801000975A TH0801000975A TH149018B TH 149018 B TH149018 B TH 149018B TH 801000975 A TH801000975 A TH 801000975A TH 0801000975 A TH0801000975 A TH 0801000975A TH 149018 B TH149018 B TH 149018B
Authority
TH
Thailand
Prior art keywords
pyridinil
cyclobutyl
piridinone
benzacipin
tetrahydro
Prior art date
Application number
TH801000975A
Other languages
Thai (th)
Other versions
TH801000975A (en
TH149018A (en
TH0801000975A (en
Inventor
นายเดวิด จีอ๊อฟฟรี่ย์ คัลลิงฟอร์ด นางสาวยู ลิ นายอลัน เจมส์ คลาร์ก
Original Assignee
แกล็กโซ กรุ๊ป ลิมิเต็ด
Filing date
Publication date
Publication of TH801000975A publication Critical patent/TH801000975A/en
Application filed by แกล็กโซ กรุ๊ป ลิมิเต็ด filed Critical แกล็กโซ กรุ๊ป ลิมิเต็ด
Publication of TH149018A publication Critical patent/TH149018A/en
Publication of TH149018B publication Critical patent/TH149018B/en
Publication of TH0801000975A publication Critical patent/TH0801000975A/en

Links

Abstract

การประดิษฐ์ปัจจุบันเกี่ยวข้อกับรูปแบบชนิดใหม่ เพื่อกระบวนการสำหรับการเตรียม รูปแบบยา และเพื่อการใช้ของรูปแบบยา ในการบำบัดความผิดปกติทางระบบประสาทและทางจิต The current invention relates to a new type of form. For the process of preparing the dosage form and for the use of the dosage form. In the treatment of neurological and mental disorders

Claims (1)

1. รูปแบบยาที่ประกอบด้วย a) 1-{6-[(3-ไซโคลบิวทิล-2,3,4,5-เตตระไฮโดร-1 H-3-เบนซาซีพิน-7-อิล)ออก ซี]-3-ไพริดินิล}-2-ไพร์โรลิดิโนน หรือเกลือที่สามารถยอมรับได้ทางเภสัช กรรมของมัน; b) สารให้ความคงตัว ซึ่งลดการเสื่อมของ 1-{6-[(3-ไซโคลบิวทิล-2,3,4,5-เตตระ ไฮโดร-1H-3-เบนซาซีพิน-7-อิล)ออกซี]-3-ไพริดินิล}-2-ไพร์โรลิดิโนน ใน รูปแบบยา เมื่อถูกเปรียบเทียบกับรูปแบบ:1. Dosage form containing a) 1- (6 - ((3-cyclobutyl-2,3,4,5-tetrahydro-1) H-3- benzacipin-7-il) exit C] -3-pyridinil} -2- piridinone Or its pharmacologically acceptable salt; b) stabilizers Which reduces the deterioration of 1- (6 - ((3-cyclobutyl-2,3,4,5-tetra Hydro-1H-3-benzazipine-7-il) oxy] -3-pyridinil} -2-pyridinone in dosage form when compared to the:
TH0801000975A 2008-02-28 New dosage form containing 1-{6-[(3-cyclobutyl-2,3,4,5,-tetrahydro-1H-3-benzazepine-7-I l)oxy]-3-pyridinyl}-2-pyrrolidinone and stabilizer TH0801000975A (en)

Publications (4)

Publication Number Publication Date
TH801000975A TH801000975A (en)
TH149018A TH149018A (en) 2016-04-26
TH149018B true TH149018B (en) 2016-04-26
TH0801000975A TH0801000975A (en) 2016-04-26

Family

ID=

Similar Documents

Publication Publication Date Title
GT201100336A (en) HETEROCYCLIC SULFONAMIDS, USES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME
TW200801029A (en) Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
MX346186B (en) Protein kinase inhibitors.
PH12013501480A1 (en) Novel heterocyclic derivatives and their use in the treatment of neurological disorders
AR059948A1 (en) PHARMACEUTICAL FORMS AND TREATMENT METHODS THAT USE A THYROSINACINASE INHIBITOR
MY144857A (en) Phamaceutical composition comprising amlodipine and losartan
IL212568A (en) 1,4-diazepane derivatives, their pharmaceutical compositions and use thereof in the manufacture of medicaments for treating a disease or disorder in a mammal
MX2008013212A (en) 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors.
BR112014001880A2 (en) substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanyloid receptor ligands
DE602005009745D1 (en) GLUCOPYRANOSYL-SUBSTITUTED BENZ DERIVATIVES, MEDICAMENTS WITH SUCH COMPOUNDS, THEIR USE AND METHOD OF MANUFACTURING THEREOF
EA201170624A1 (en) ISONICOTINAMIDE ANTAGONISTS OF OREXIN RECEPTORS
CL2007002288A1 (en) COMPOUNDS DERIVED FROM CONDENSED IMIDAZOL-AMINA, INHIBITORS OF BETA-SECRETASA; PREPARATION PROCESS; PHARMACEUTICAL COMPOSITION, USEFUL FOR THE TREATMENT, PREVENTION OR IMPROVEMENT OF DISEASES SUCH AS ALZHEIMER'S DISEASE, DETERIORATION
JO2686B1 (en) compounds
JO2645B1 (en) Compounds
CR20120289A (en) DIOXA-BICYCLE DERIVATIVES [3.2.1] OCTANO-2,3,4-TRIOL
IL210174A0 (en) 4-(pyridin-4-yl)-1h-(1,3,5)triazin-2-one derivatives as gsk3-beta inhibitors for the treatment of neurodegenerative diseases
CY1112233T1 (en) 1,2,3-TRIAZOLIS PRODUCT FOR USE AS STEATOYLO-COA SUSPENSIONS
CL2009000906A1 (en) 4-imidazolyl and 4-triazolyl derivative compounds of 2- (6- (4-cycloalkylpiperazin-1-yl) pyrimidin-4-yl) -1h-pyrazol-3 (2h) one inhibitors of hif-prolyl-4-hydroxylases ; preparation procedure; pharmaceutical composition; and use of the compound in the treatment of cardiovascular, renal and hematological diseases.
PL3689346T3 (en) 3,6-Disubstituted xanthyl salts for the treatment of tauopathies
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
EA200970817A1 (en) DOSAGE FORM CONTAINING 1 {6 - [(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) oxy] -3-pyridinyl} -2-pyrrolidinone or a salt thereof and a stabilizer WHICH REDUCES HIS DEGRADATION
MA32841B1 (en) Compounds of cyclondica dipseibeptides and their use as drugs
AR068438A1 (en) DERIVED FROM 6-PIRIMIDINIL-PIRIMID-2-ONA
HUE037261T2 (en) 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide for the treatment of migraine via the oral or intravenous route
PL2244703T3 (en) The drug, its manufacture and use in the treatment of painful neuropathies